Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0K9E stock hub

LON/0K9E has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0K9Eis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

204.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0K9E

In the news

Latest news · LON/0K9E

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.2

P25 n/aP50 n/aP75 n/a

Trailing P/E19.9

P25 n/aP50 n/aP75 n/a

ROE34.9

P25 n/aP50 n/aP75 n/a

ROIC21.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0K9E market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	75,267
Employees Change	-616%
Employees Change Percent	-0.81
Enterprise value	$234.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Isin	US66987V1098
Last refreshed	2026-05-10
Market cap	$204.2B
Price	$146
Price currency	USD
Rev Per Employee	569,264.12x
Sic	2834
Symbol	lon/0K9E
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.02%
EV Earnings	22.91x
EV/EBIT	16.85x
EV/EBITDA	13.37x
EV/FCF	17.68x
EV/Sales	5.48x
FCF yield	6.5%
Forward P/E	16.23x
P/B ratio	6.93x
P/E ratio	19.92x
P/S ratio	4.76x
PE Ratio10 Y	20.03x
PE Ratio3 Y	18.04x
PE Ratio5 Y	17.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.56%
EBITDA Margin	40.51%
FCF margin	30.99%
Gross margin	75.55%
Gross Profit	$32.4B
Gross Profit Growth	6.14%
Gross Profit Growth Q	-2.95%
Gross Profit Growth3 Y	10.99%
Gross Profit Growth5 Y	3.98%
Net Income	$10.2B
Net Income Growth	5.25%
Net Income Growth Q	-12.48%
Net Income Growth3 Y	24.42%
Net Income Growth5 Y	11.21%
Pretax Margin	27.9%
Profit Margin	23.92%
Profit Per Employee	$136,173
ROA	10.54
Roa5y	7.4
ROCE	21.14
ROE	34.93
Roe5y	23.91
ROIC	21.1
Roic5y	17.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	33.86%
Cagr3y	15.15%
Cagr5y	13.93%
Div CAGR3	6.59%
Div CAGR5	12.67%
EPS Growth	9.48
EPS Growth Q	-9.34
EPS Growth3 Y	29.06
EPS Growth5 Y	14.94
FCF Growth	-0.4%
FCF Growth Q	-1.8%
FCF Growth3 Y	6.01%
FCF Growth5 Y	7.94%
OCF Growth	0.93%
OCF Growth Q	0.85%
OCF Growth10 Y	5.03%
OCF Growth3 Y	7.25%
OCF Growth5 Y	7.67%
Revenue Growth	6.31x
Revenue Growth Q	-0.71x
Revenue Growth3 Y	10.71x
Revenue Growth5 Y	2.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.52
Assets	$89.8B
Cash	$5.2B
Current Assets	$19.5B
Current Liabilities	$23B
Debt	$35.6B
Debt EBITDA	$2.03
Debt Equity	$1.21
Debt FCF	$2.68
Equity	$29.5B
Interest Coverage	15.14
Liabilities	$60.3B
Long Term Assets	$70.2B
Long Term Liabilities	$37.3B
Net Cash	$-30.4B
Net Cash By Market Cap	$-14.88
Net Debt EBITDA	$1.75
Net Debt Equity	$1.03
Net Debt FCF	$2.29
Tangible Book Value	$-21.6B
Tangible Book Value Per Share	$-11.32
WACC	6.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	2.28
Net Working Capital	$-2.9B
Quick ratio	0.53
Working Capital	$-3.6B
Working Capital Turnover	$-7.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.8%
Dividend Growth	14.97%
Dividend Growth Years	4%
Dividend per share	$3
Dividend Years	9
Dividend Yield	2.02%
Ex Div Date	2026-03-11
Last Dividend	$3
Payout Frequency	Annual
Payout Ratio	64.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	33.83%
200-day SMA	138
3Y total return	52.71%
50-day SMA	152.4
50-day SMA vs 200-day SMA	50over200
5Y total return	91.93%
All Time High	170.3
All Time High Change	-14.14%
All Time High Date	2026-02-27
All Time Low	71.75
All Time Low Change	103.78%
All Time Low Date	2020-03-17
ATR	3.38
Beta	0.49
Ch YTD	5.74
High	146.7
High52	170.3
High52 Date	2026-02-27
High52ch	-14.14%
Low	145
Low52	105.7
Low52 Date	2025-05-14
Low52ch	38.32%
Ma50ch	-4.09%
Price vs 200-day SMA	5.91%
RSI	44.6
RSI Monthly	61.89
RSI Weekly	51.64
Sharpe ratio	1.27x
Sortino ratio	2.15
Total Return	5.82%
Tr YTD	8.44
Tr1m	-3.07%
Tr1w	-0.48%
Tr3m	-3.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$14B
Operating Income Growth	4.47
Operating Income Growth Q	-12.37
Operating Income Growth3 Y	20.99
Operating Income Growth5 Y	10.06
Operating margin	32.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,816,121,384%
Net Borrowing	10,655,024,364
Shares Insiders	0.11%
Shares Institutions	44.44%
Shares Qo Q	-0.67%
Shares Yo Y	-3.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$12.4B
Average Volume	4,215.75x
Bv Per Share	15.29
CAPEX	$-1.2B
Ch1m	-3.07
Ch1w	-0.48
Ch1y	30.5
Ch3m	-6.28
Ch3y	39.97
Ch5y	66.68
Ch6m	15.28
Change	0.55%
Change From Open	0.56
Close	145.4
Days Gap	-0.01
Depreciation Amortization	3,300,079,486
Dollar Volume	64,332.4
Earnings Date	2026-04-28
EBIT	$14B
EBITDA	$17.4B
EPS	$5.29
F Score	5
FCF	$13.3B
FCF EV Yield	5.65x
Financing CF	-2,075,015,700
Fiscal Year End	December
Founded	1,996
Goodwill	19,672,111,966
Graham Number	59.04875
Graham Upside	-59.61
Income Tax	$1.7B
Investing CF	-12,831,018,615
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	$82.31
Lynch Upside	-43.71
Ma150	143.2
Ma150ch	2.08%
Ma20	147.9
Ma20ch	-1.16%
Net CF	-143,130,645
Next Earnings Date	2026-07-21
Open	145.4
P FCF Ratio	15.37
P OCF Ratio	14.06
Payment Date	2026-03-16
Position In Range	70.62
Ppne	8,976,744,332
Price Date	2026-05-08
Price EBITDA	$11.76
Relative Volume	0.1x
Revenue	42,846,802,290x
SBC By Revenue	2.01x
Share Based Comp	861,055,785
Tax By Revenue	4.01x
Tax Rate	14.38%
Tr6m	18.22%
Volume	440
Z Score	3.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0K9E dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$3.00 annual per share

Payout ratio

+64.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.7%

4 consecutive years of growth

Total shareholder yield

+5.8%

Next ex-dividend date: 2026-03-11

Performance

LON/0K9E stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0K9E?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.8%

Negative means the company is buying back shares.

Technical

LON/0K9E momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.6

Neutral momentum band

Price vs 200-day MA

+5.9%

50/200-day relationship not available

Beta (5Y)

0.49

Less volatile than the market

Sharpe ratio

1.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0K9E

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0K9E stock rating?

lon/0K9E is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0K9E analysis?

The full report lives at /stocks/lon/0K9E/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0K9E?

The latest report frames lon/0K9E around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0K9E page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.